Pura Vida Investments’s Transmedics TMDX Stock Holding History

Pura Vida Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-55,000	Closed	-$4.17M	–	97
2023 Q1	$4.17M	Sell	55,000 -35,000	-39%	-$2.42M	0.42%	53
2022 Q4	$5.55M	Sell	90,000 -30,000	-25%	-$1.59M	0.29%	84
2022 Q3	$5.01M	Buy	+120,000	New	+$5.22M	0.29%	83

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Pura Vida Investments's TMDX Position: Q2 2023 in Review

Pura Vida Investments sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 55,000 shares — an estimated $4.17M sold.

Pura Vida Investments first reported a position in TMDX in Q3 2022 and held it in 3 quarters. The position peaked at $5.55M in Q4 2022. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

Pura Vida Investments reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
Pura Vida Investments sold 55,000 Transmedics shares in Q2 2023, an estimated $4.17M.
Pura Vida Investments first reported a position in Transmedics in Q3 2022 and held it in 3 quarters.
Pura Vida Investments's Transmedics position peaked at $5.55M in Q4 2022.
240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.